28 Participants NeededMy employer runs this trial

Transcranial Focused Ultrasound for Smell

(O-tFUS Trial)

NC
Overseen ByNicole Cash, Study Coordinator
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Medical University of South Carolina
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This study investigates the causal effects of low-intensity transcranial focused ultrasound (tFUS) on odor valence perception and odor-elicited avoidance behaviors in healthy adults. Participants undergo sham and active tFUS targeting the amygdala (AMYG) and ventral striatal olfactory tubercle (VSOT) in a within-subject, randomized, sham-controlled crossover design. Outcomes include subjective odor ratings and objective neurophysiological and behavioral indices of odor valence processing. This research is exploratory and mechanistic in nature and is not intended to evaluate clinical safety or therapeutic efficacy.

Are You a Good Fit for This Trial?

This trial is for healthy adults aged 18-65 who have a normal sense of smell and can understand English well enough to complete study tasks. Participants must be able to give informed consent.

Inclusion Criteria

Ability to provide informed consent
Normal olfactory function (Sniffin' Sticks total TDI ≥ 30.75)
I am a healthy adult.
See 2 more

Exclusion Criteria

I have sinus or nasal problems that affect my breathing or sense of smell.
MRI or tFUS contraindications (e.g., metal implants, claustrophobia, pregnancy)
Positive urine drug screen
See 1 more

What Are the Treatments Tested in This Trial?

Interventions

  • transcranial focused ultrasound (tFUS)

Trial Overview

The study tests the effects of low-intensity transcranial focused ultrasound (tFUS) on how people perceive odors and react to them. Each participant receives both real and sham tFUS in random order, targeting specific brain areas related to smell.

How Is the Trial Designed?

3

Treatment groups

Experimental Treatment

Placebo Group

Group I: Active tFUS targeting the Ventral Striatal Olfactory Tubercle (VSOT)Experimental Treatment1 Intervention
Group II: Active tFUS targeting the Amygdala (AMYG)Experimental Treatment1 Intervention
Group III: Sham tFUSPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Medical University of South Carolina

Lead Sponsor

Trials
994
Recruited
7,408,000+

National Institute on Deafness and Other Communication Disorders (NIDCD)

Collaborator

Trials
377
Recruited
190,000+

National Institutes of Health (NIH)

Collaborator

Trials
2,896
Recruited
8,053,000+